uniQure N.V.
QURE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590560
In the last 90 days, uniQure N.V. insiders filed 0 open-market purchases and 3 sales; 254 institutions reported holding it in 13F filings for Q2 2026, worth $3.02B in total; Maverick Capital is the only superinvestor holding it.
Superinvestors holding QURE, Q2 2026
1 superinvestor reports holding uniQure N.V. on Form 13F, worth $42.6M in total. Weight is uniQure N.V.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | 0.4% | 925,383 | $42.6M | Added+32.6% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of QURE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+32.6%)
Q1 2026
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+5.4%)
Q4 2025
1 superinvestor holding at quarter end